PCG
AUPH icon

Private Capital Group’s Aurinia Pharmaceuticals AUPH Stock Holding History

Private Capital Group’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$16K Hold
1,632
– – 0.01% 899
2022
Q1 		$20K Sell
1,632
-204
-11% -$3.15K ﹤0.01% 1026
2021
Q4 		$42K Sell
1,836
-236
-11% -$5.59K 0.01% 758
2021
Q3 		$46K Buy
2,072
+581
+39% +$9.22K 0.01% 714
2021
Q2 		$19K Sell
1,491
-1,140
-43% -$14.5K ﹤0.01% 1114
2021
Q1 		$34K Buy
+2,631
New +$38.2K 0.01% 792

Other funds holding AUPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

Private Capital Group's AUPH Position: Q2 2022 in Review

Private Capital Group held its Aurinia Pharmaceuticals (AUPH) position steady in Q2 2022 at 1,632 shares worth $16K. The position accounts for 0.01% of the portfolio, ranked #899.

Private Capital Group first reported a position in AUPH in Q1 2021 and has held it in 6 quarters since. The position peaked at $46K in Q3 2021. 199 funds tracked by Wall St. Rank hold AUPH as of Q2 2022.

  • Private Capital Group held 1,632 shares of Aurinia Pharmaceuticals worth $16K as of Q2 2022.
  • Private Capital Group left its Aurinia Pharmaceuticals share count unchanged in Q2 2022.
  • Aurinia Pharmaceuticals made up 0.01% of Private Capital Group's portfolio in Q2 2022, its #899 holding.
  • Private Capital Group first reported a position in Aurinia Pharmaceuticals in Q1 2021 and has held it in 6 quarters since.
  • Private Capital Group's Aurinia Pharmaceuticals position peaked at $46K in Q3 2021.
  • 199 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2022.

Based on Private Capital Group's 13F filing for Q2 2022, filed 28 Jul 2022.